Moreover, our findings demonstrate that the observed disparities in NLRP3 inflammasome activation between the groups may stem from a multitude of factors, including the presence of comorbidities, especially obesity itself, and the duration of underlying illnesses. This evidence concerns the gene NLRP3 and obesity due to melanocortin 4 receptor deficiency.